Flerie Invest AB

Venture Capital Active Sweden
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
4
Rounds led
1
Rounds' value
$84.0M
total disclosed, rounds participated
Stages
—

Portfolio · 1

KAHR Medical
Fusion Proteins for Treating Cancer and Autoimmune Diseases
Led ★ 4 rounds $84.0M committed Latest: 2021-06

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Flerie Invest AB's primary investment focus?
Flerie Invest AB primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and investment rounds concentrated in this area.
Can you name a notable company in Flerie Invest AB's portfolio?
KAHR Medical, a company developing fusion proteins for treating cancer and autoimmune diseases, is a notable company in Flerie Invest AB's portfolio. KAHR Medical has raised $118.27M in funding.
What is Flerie Invest AB's typical investment range?
Flerie Invest AB typically invests between $7.5M and $46.5M per round.
When was Flerie Invest AB founded?
Flerie Invest AB was founded in 2019.
What is Flerie Invest AB's most recent investment activity?
Flerie Invest AB's most recent recorded investment round occurred in June 2021.